Filing Details
- Accession Number:
- 0001562180-24-002309
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-05 17:40:25
- Reporting Period:
- 2024-03-01
- Accepted Time:
- 2024-03-05 17:40:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1944069 | A Richard Colvin | C/O Bluebird Bio, Inc 455 Grand Union Boulevard Somerville MA 02145 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-03-01 | 6,770 | $1.53 | 118,368 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Acquisiton | 2024-03-01 | 199,000 | $0.00 | 199,000 | $1.56 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
199,000 | 2034-03-01 | No | 4 | A | Direct |
Footnotes
- Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- The range in prices for the transaction reported on this line was $1.52 to $1.55. The average weighted price was $1.5276. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This stock option will vest over a four-year period at the rate of 25% on the first anniversary of March 1, 2024, and then in equal monthly installments for the remaining 36 months.